Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958) |
---|
04/01/2009 | EP2042168A1 Inhalation device comprising phenethanolamine derivatives for treatment of respiratory diseases |
04/01/2009 | EP2041069A1 Benzyl amines, a process for their production and their use as anti-inflammatory agents |
04/01/2009 | CN101400644A Processes for the preparation of atomoxetine hydrochloride |
04/01/2009 | CN101397259A N,N-(2-hydroxyl-3-mehtoxybenzyl)diamine cerium complexes and preparation method thereof |
03/31/2009 | US7511073 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
03/31/2009 | CA2458679C Oxidation hair dyes containing 3-aminophenol derivatives, and novel 3-aminophenol derivatives |
03/31/2009 | CA2292549C Use of colchinol derivatives as vascular damaging agents |
03/26/2009 | WO2008151179A3 Substituted phenethylamines |
03/25/2009 | EP2038249A1 Process for preparing gabapentin |
03/24/2009 | US7507545 Ion channel modulating activity method |
03/19/2009 | WO2009035020A1 Novel dihydronaphthalene compound and use thereof |
03/19/2009 | WO2009034432A2 Novel compounds active as muscarinic receptor antagonists |
03/19/2009 | WO2009012039A3 Crystalline polymorphs |
03/19/2009 | CA2699463A1 Novel compounds active as muscarinic receptor antagonists |
03/18/2009 | EP2035566A2 Materials and complexes for the delivery of biologically-active material to cells |
03/18/2009 | EP2035366A1 Process for preparation of 0-desmethylvenlafaxine and its analogues |
03/18/2009 | CN101386580A Aminopropancdiols derivates, preparation method thereof and medicament composition and use thereof |
03/18/2009 | CN100469759C Toremifene crystallization method |
03/17/2009 | CA2433684C Novel couplers for use in oxidative hair dyeing |
03/12/2009 | US20090069440 Deuterium-enriched atomoxetine |
03/12/2009 | US20090068273 Prophylaxis of respiratory disorders such as asthma; composition with PDE4 inhibitor, corticosteroid hibitor or anticholinergic agent; 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol or salt |
03/12/2009 | US20090068113 Amphiphilic squaraine dyes, process for preparation thereof and use thereof |
03/11/2009 | EP2032525A1 Deuterated aminoglycidyl compounds |
03/11/2009 | EP2032524A1 Coupling compounds and hair dyeing compositions containing them |
03/11/2009 | EP2032523A1 Process for preparation of alkoxylated alkylamines / alkyl ether amines with peaked distribution |
03/11/2009 | EP1633697B1 Method for the production of substituted 3-aryl-butyl amine compounds |
03/11/2009 | CN101381319A Preparation method of 2,2-bis[3-amino-4(2,6-binitro-4-trifluoromethylphenoxy)phenyl] hexafluoropropane |
03/10/2009 | US7501542 Highly-packed polycationic ammonium, sulfonium and phosphonium lipids |
03/10/2009 | US7501441 for treating uterine fibroid disease; [2-(4-hydroxyphenyl)-6-hydroxynaphthalen-1-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methane; therapy for post manupausal women |
03/10/2009 | CA2377233C Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof |
03/10/2009 | CA2336853C Phenoxyacetic acid derivatives and medicinal compositions containing the same |
03/05/2009 | US20090062530 Substituted arylalkanoic acid derivatives and use thereof |
03/05/2009 | US20090062353 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
03/04/2009 | EP1472209B1 Lipoxin a4 analogs |
03/04/2009 | EP0839162B1 Optical clarity stabilizing fatty alkyl diethanolamines |
03/03/2009 | US7498436 Substituted hydroxyethylamines |
03/03/2009 | CA2450501C Asymmetric benzoxanthene dyes |
03/03/2009 | CA2328348C 2-methylpropionic acid derivatives and medicinal compositions containing the same |
02/26/2009 | WO2009023964A1 Renin inhibitors |
02/26/2009 | CA2696689A1 Renin inhibitors |
02/25/2009 | CN101374803A Cyclic amine derivatives and their uses |
02/24/2009 | CA2417361C New phenyl- and phenylalkyl-substituted ethanolamines and ethylenediamines |
02/24/2009 | CA2321543C Methods for the preparation of an n-bis-[2-(1,2-dicarboxy-ethoxy)-ethyl]amine derivative and products of the methods and their uses |
02/19/2009 | WO2008148057A3 Cationic lipids compositions and methods for enhancing immune responses to vaccines |
02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
02/18/2009 | EP2025664A2 Aromatic diamine compound and aromatic dinitro |
02/18/2009 | EP2025661A1 Fluoroalkyloxy-containing combretastatin derivatives, preparation and use thereof |
02/18/2009 | EP2024322A1 Fragrance precursor |
02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
02/18/2009 | CN101367740A Aromatic diamine compound and aromatic dinitro compound |
02/12/2009 | WO2009020910A1 Fluoroalkyl surfactants |
02/12/2009 | WO2009018959A1 Salts of tramadol and naproxen and their crystal forms in the treatment of pain |
02/12/2009 | US20090042994 Pesticide phenyloxy substituted phenylamidine derivatives |
02/12/2009 | US20090042981 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine |
02/12/2009 | CA2690232A1 Fluoroalkyl surfactants |
02/11/2009 | EP2022778A1 A crystalline form of (R,R)-tramadol-(S)-naproxene salt |
02/10/2009 | US7488758 Levalbuterol hydrochloride polymorph B |
02/10/2009 | CA2386690C Pharmaceutical tramadol salts |
02/10/2009 | CA2336691C Ligands for metals and metal-catalyzed processes |
02/05/2009 | WO2009018169A1 Substituted cyclohexanols |
02/05/2009 | DE19963179B4 Substituierte 1- und 2-Naphthol-Mannichbasen Substituted 1- and 2-naphthol Mannich bases |
02/04/2009 | CN101360698A Substituted aryloxypropylamines with serotoninergic and/or norepinephrinergic activity |
02/04/2009 | CN101357892A Preparation method of 4,4¡¯-aminodiphenylamine |
02/04/2009 | CN100457714C Preparing and separating purifying method for 3,4'-diamino diphenyl ether |
02/04/2009 | CN100457088C Pharmaceutical composition comprising lipids comprising polar and nonpolar moiety parts |
02/03/2009 | CA2327635C Uracil compounds and use thereof |
01/29/2009 | WO2009013376A1 Polyimides with piezoelectric properties |
01/29/2009 | US20090030084 Compositions and Methods of Use of Electron Transport System Inhibitors |
01/29/2009 | US20090029903 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors |
01/28/2009 | CN101353341A Colorant reacted by oxyalkylene-substituted aminophenol intermediate |
01/28/2009 | CN101353310A Preparation of 3,3í»-diamino-4,4í»-bis(2,6-dinitro-4-trifluoromethyl phenoxy) biphenyl |
01/28/2009 | CN100455560C Medicine precursor containing long chain fatty acyl group substituted venlafaxine and its prepn and use |
01/27/2009 | US7482491 Amino alcohol derivative, addition salt thereof, and immunosuppressant |
01/27/2009 | US7482489 Enantiomerically pure (R)-albuterol dibenzoyltartrate and protected analogs thereof |
01/22/2009 | WO2008110281A3 3,4-disubstituted phenoxyphenylamidines and use thereof as fungicides |
01/22/2009 | US20090023929 Intermediate of 6-Substituted 1-Methyl-1-H-Benzimidazole Derivative and Method for Producing Same |
01/22/2009 | US20090023926 Biopolymer ionization; liquid chromatography |
01/22/2009 | US20090023791 PH-dependent NMDA receptor antagonists |
01/21/2009 | EP2017267A1 Synthesis of statins |
01/21/2009 | EP2017257A1 2-aminobutanol compound and use thereof for medical purposes |
01/21/2009 | EP2017244A2 Chiral binaphtol derivatives as alanine racemase mimics with powerful hydrogen bond donors: their use for optical resolution and optical inversion |
01/21/2009 | EP1546227A4 Polyether polyamine agents and mixtures therefor |
01/21/2009 | CN101351441A Process for preparing substituted dimethyl(3-arylbutyl)amine compounds by means of homogeneous catalysis |
01/21/2009 | CN100453529C Aryl sulfonamides and analogues thereof and their use in treatment of neurodegenerative diseases |
01/20/2009 | US7479573 Cationic lipids capable of facilitating transport of biologically active agents or substances into cells; lipid aggregate macromolecular complex interacts with cells making the polyanionic macromolecule available for absorption and uptake by the cell |
01/15/2009 | WO2007109791A9 Alkoxylated alkylamines or alkyl ether amines with peaked distribution |
01/15/2009 | US20090017057 Stimulation of an immune response by cationic lipids |
01/15/2009 | CA2692738A1 O-desmethylvenlafaxine |
01/14/2009 | EP2014643A1 Para-ethoxyaniline derivatives increasing the antiknock rating of hydrocarbon fuels and compositions based thereon |
01/14/2009 | CN101346346A Amine compound and use thereof for medical purposes |
01/14/2009 | CN101343238A Preparation method for 3-methoxy-N-methyldiphenylamine |
01/08/2009 | WO2009005794A2 Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders |
01/08/2009 | WO2009005024A1 Method for producing optically active amine |
01/08/2009 | WO2009004914A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group |
01/08/2009 | WO2009003589A1 A process for the palladium-catalyzed coupling of terminal alkynes with aryl tosylates |
01/08/2009 | WO2008110280A3 Phenoxy substituted phenylamidine derivatives and their use as fungicides |
01/08/2009 | WO2008065681A3 Process for preparation of ivabradine hydrochloride |
01/08/2009 | US20090012159 High purity bases of 3,3-diphenylpropylamino monoesters |
01/08/2009 | US20090012093 Receptor Function Regulator |
01/08/2009 | CA2699965A1 Pet probe having an alkoxy group substituted by fluorine and hydroxy group |